WeTrials
Recruiting

A Phase 1 Trial to Evaluate the Safety of IL13Rα2-Targeting Chimeric Antigen Receptor (CAR) T Cells With CRISPR Knockout of TGFβR2 in Patients With Recurrent or Progressive High-Grade Glioma (HGG)

What is this study?

This early-stage study tests a special type of immunotherapy using your own immune cells, called CAR T-cell therapy, to target and fight a recurrent or progressive brain tumor. By modifying these cells in a lab, researchers hope to safely and effectively attack the cancer cells while protecting the immune cells from signals that block them.

Who can participate?

You may be able to join if you are 18 or older, have a high-grade glioma (a type of aggressive brain tumor) that has returned or worsened, and are generally well enough to perform daily activities. Certain conditions, such as uncontrolled seizures or taking specific medications like bevacizumab, mean you cannot participate.

What will happen?

You will have your blood drawn so researchers can collect and modify your immune cells in the lab, and you will receive them back through a small tube placed in your skull. The study also involves various tests and scans, such as MRIs, heart checks, and possible tissue samples, to monitor your health and how your body responds.

Where and when?

This study is currently recruiting participants in Duarte, California, United States.

Key Points
  • 1Uses your own modified immune cells to target brain tumors
  • 2Involves delivering the treatment directly into the skull
  • 3Requires regular check-ups, scans, and blood tests to monitor safety

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Recurrent Astrocytoma, IDH-Mutant, Grade 3Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.